Evidence map›Paper›PMID 31843472›Full record

ArticlePhysiology & behavior2020

Microinjection of urotensin II into the pedunculopontine tegmentum leads to an increase in the consumption of sweet tastants.

Robert Ettaro, Tamara Markovic, Derek Daniels, Duncan Aa MacLaren, Stewart D Clark

Open access · greenAbstract read
In one paragraph

Article in Physiology & behavior, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Robert EttaroDepartment of Pharmacology and Toxicology, University at Buffalo, Buffalo, NY 14214, United States.
Tamara MarkovicDepartment of Pharmacology and Toxicology, University at Buffalo, Buffalo, NY 14214, United States.
Derek DanielsDepartment of Psychology and the Center for Ingestive Behavior Research, University at Buffalo, Buffalo, NY 14214, United States.
Duncan Aa MacLarenDepartment of Pharmacology and Toxicology, University at Buffalo, Buffalo, NY 14214, United States.
Stewart D ClarkDepartment of Pharmacology and Toxicology, University at Buffalo, Buffalo, NY 14214, United States.
University at Buffalo, State University of New York · US

Funding

Modulation of Dopaminergic VTA Neurons by Urotensin IIR00DA024754 · NIDA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI CLARK, STEWART DONALDSON · 2011 to 2013
$775k
NIDA NIH HHS R00 DA024754
6 · The paper itself

Abstract

The pedunculopontine tegmentum (PPTg) plays a role in processing multiple sensory inputs and innervates brain regions associated with reward-related behaviors. The urotensin II receptor, activated by the urotensin II peptide (UII), is selectively expressed by the cholinergic neurons of the PPTg. Although the exact function of cholinergic neurons of the PPTg is unknown, they are thought to contribute to the perception of reward magnitude or salience detection. We hypothesized that the activation of PPTg cholinergic neurons would alter sensory processing across multiple modalities (ex. taste and hearing). Here we had three aims: first, determine if cholinergic activation is involved in consumption behavior of palatable solutions (sucrose). Second, if so, distinguish the impact of the caloric value by using saccharin, a zero calorie sweetener. Lastly, we tested the UII-mediated effects on perception of acoustic stimuli by measuring acoustic startle reflex (ASR). Male Sprague-Dawley rats were bilaterally cannulated into the PPTg, then placed under food restriction lasting the entire consumption experiment (water ad lib.). Treatment consisted of a microinjection of either 1 μL of aCSF or 1 μL of 10 μM UII into the PPTg, and the rats were immediately given access to either sucrose or saccharin. For the remaining five days, rats were allowed one hour access per day to the same sweet solution without any further treatments. During the saccharin experiment rats were tested in a contact lickometer which recorded each individual lick to give insight into the microstructure of the consumption behavior. ASR testing consisted of a baseline (no treatment), treatment day, and two additional days (no treatment). Immediately following the microinjection of UII, consumption of both saccharin and sucrose increased compared to controls. This significant increase persisted for days after the single administration of UII, but there was no generalized arousal or increase in water consumption between testing sessions. The effects on ASR were not significant. Activating cholinergic PPTg neurons may lead to a miscalculation of the salience of external stimuli, implicating the importance of cholinergic input in modulating a variety of behaviors. The long-lasting effects seen after UII treatment support further research into the role of sensory processing on reward related-behaviors at the level of the PPTg cholinergic neurons.

Indexed as

Pedunculopontine Tegmental NucleusAcoustic StimulationAnimalsFeeding BehaviorMaleMicroinjectionsParasympathetic Nervous SystemRatsRats, Sprague-DawleyReflex, StartleRewardSaccharinSucroseSweetening AgentsTasteUrotensinsSaccharinSucroseSweetening Agentsurotensin IIUrotensinsCholinergicPedunculopontine tegmentumSensory processingUrotensin II

Identifiers

PMID31843472
PMCPMC8691100
OpenAlexW2996441453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.